annabelle · 2019-10-02 · of chemotherapies on cardiotoxicity. Dr. Annabelle has a focus on...
1
FOLLOW US JOURNAL OF TM a MACE Media Publication Annabelle Manalo Ph.D- Advisory Dr. Annabelle Manalo is a cell and developmental biologist from Vanderbilt University in Nashville, Tennessee. She has a background in neuroscience at Georgetown University and has recently studied genetic mutations that mimic the offset effects of chemotherapies on cardiotoxicity. Dr. Annabelle has a focus on clinical trials which encourage precision-based medicine through basic science application. During her studies in the new Cardio-Oncology industry, Dr. Annabelle gave birth to her son Macario. As a newborn baby, Macario suffered from a stroke and uncontrollable seizures. Macario had 38% of his brain resected at 5 weeks old. As a concerned mother, Dr. Annabelle went against all odds and developed her son a cannabinoid product to replace all of his medications at 6 months old. Now, as a 3 year old boy, Macario has no developmental deficits and is a healthy growing preschooler. Their journey towards recovery has filled Dr. Annabelle with a passion and commitment to the cannabis industry and more generally, a use of scientific knowledge as an application in a real time setting. Treating a person for a person. Currently, Dr. Annabelle has an interest in cannabinoid therapeutic benefits on specific conditions and disease. To further her mission to heal the world through cannabis, she consults for several governments and companies in regards to the legalization/standardization process and research protocols. Notably, she served as Scientific Director to Tikun Olam - a mission-driven organization at the forefront of global cannabis research, is on the advisory board of Quanta - a polarization based technology group, and her own company Masaya - focusing on scientifically backed production and research. Dr. Annabelle will be launching her first book by ForbesBooks entitled “Mighty Flower” in a mission to provide a reality of the current cannabis industry while identifying the scientific gaps. Dr. Annabelle hopes to use her story and scientific experience to promote utilizing the cannabis plant in a defined, therapeutic design. Annabelle Manalo, PhDwww.doctorannabelle.com “Dr. Annabelle will be launching her first book by ForbesBooks entitled “Mighty Flower” in a mission to provide a reality of the current cannabis industry while identifying the scientific gaps. ”
Transcript of annabelle · 2019-10-02 · of chemotherapies on cardiotoxicity. Dr. Annabelle has a focus on...
FOLLOW US
J O U R N A L O F
TM
a MACE Media Publ icat ion
Annabelle ManaloPh.D- Advisory
Dr. Annabelle Manalo is a cell and developmental biologist from Vanderbilt University in Nashville, Tennessee. She has a background in neuroscience at Georgetown University and has recently studied genetic mutations that mimic the o�set e�ects of chemotherapies on cardiotoxicity. Dr. Annabelle has a focus on clinical trials which encourage precision-based medicine through basic science application. During her studies in the new Cardio-Oncology industry, Dr. Annabelle gave birth to her son Macario. As a newborn baby, Macario su�ered from a stroke and uncontrollable seizures. Macario had 38% of his brain resected at 5 weeks old. As a concerned mother, Dr. Annabelle went against all odds and developed her son a cannabinoid product to replace all of his medications at 6 months old. Now, as a 3 year old boy, Macario has no developmental de�cits and is a healthy growing preschooler. Their journey towards recovery has �lled Dr. Annabelle with a passion and commitment to the cannabis industry and more generally, a use of scienti�c knowledge as an application in a real time setting. Treating a person for a person.
Currently, Dr. Annabelle has an interest in cannabinoid therapeutic bene�ts on speci�c conditions and disease. To further her mission to heal the world through cannabis, she consults for several governments and companies in regards to the legalization/standardization process and research protocols. Notably, she served as Scienti�c Director to Tikun Olam - a mission-driven organization at the forefront of global cannabis research, is on the advisory board of Quanta - a polarization based technology group, and her own company Masaya - focusing on scienti�cally backed production and research. Dr. Annabelle will be launching her �rst book by ForbesBooks entitled “Mighty Flower” in a mission to provide a reality of the current cannabis industry while identifying the scienti�c gaps. Dr. Annabelle hopes to use her story and scienti�c experience to promote utilizing the cannabis plant in a de�ned, therapeutic design.
Annabelle Manalo, PhDwww.doctorannabelle.com
“Dr. Annabelle will be launching her �rst
book by ForbesBooks entitled“Mighty Flower”
in a mission to providea reality of the currentcannabis industry while
identifying thescienti�c gaps.”
